-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:Albemarle第一季度业绩强劲,净销售额达14.3亿美元(同比增长33%,超出市场预期8.4%),调整后每股收益为2.95美元,而上年同期亏损0.18美元,超出市场预期1.64美元。调整后EBITDA同比增长148%至6.64亿美元,表明随着锂价回升,公司运营杠杆效应显著。储能业务引领复苏,销售额达8.91亿美元(同比增长70%),主要得益于价格上涨(增长51%)和销量增长(增长14%),调整后EBITDA飙升196%至5.51亿美元。管理层根据锂价提供了2026年的业绩展望。假设2025财年平均价格(约10美元/公斤液态碳当量)预测销售额为41亿至43亿美元,调整后EBITDA为9亿至10亿美元;而2026年第一季度平均价格(约20美元/公斤液态碳当量)则预测销售额为57亿至60亿美元,调整后EBITDA为24亿至26亿美元。我们认为,ALB通过削减13亿美元债务和出售资产获得6.48亿美元收益,优化了资产负债表,从而增强了其财务灵活性。ALB仍有望实现每年1亿至1.5亿美元的成本改善目标,同时保持5.5亿至6亿美元的稳健资本支出预期。
Related Articles
StarHub's Net Attributable Profit Falls 81% in Q1
StarHub's (SGX:CC3) net attributable profit to shareholders plunged 81% in the first quarter of the year to SG$5.9 million from SG$31.8 million a year earlier, according to a Thursday filing with the Singapore Exchange.Revenue declined 6.1% year over year to SG$507.3 million from SG$540.5 million, mainly due to an across-the-board decline in services revenue.
Meesho Narrows Consolidated Loss in Fiscal Q4
Meesho (NSE:MEESHO, BOM:544632) narrowed its consolidated attributable loss to 1.66 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 13.9 billion rupees a year ago.Loss per share contracted to 0.36 rupees from a loss per share of 3.39 rupees a year earlier, the online marketplace said in a filing to the Indian stock exchanges on Wednesday. The loss per share was lower than the 0.73 rupees estimated by the analysts polled by Visible Alpha.Revenue from operations in fiscal Q4 increased to 35.3 billion rupees from 24.0 billion rupees a year ago. This is a tad higher than Visible Alpha's estimate of 35.2 billion rupees a year ago.
Changchun High-Tech Gets Regulatory Nod for Gouty Arthritis Drug
Changchun High-Tech Industry (SHE:000661) subsidiary Changchun Genescience Pharmaceutical obtained China's regulatory approval to manufacture and market its fuxinqibai monoclonal antibody injection.The drug is indicated for acute gouty arthritis attacks in adults poorly responsive to standard therapies, according to a Thursday filing with the Shenzhen bourse.